Lisa Gaston (Dobogai)
About Lisa Gaston (Dobogai)
Lisa Gaston (Dobogai) is the Associate Director of CAR T Training at Bristol Myers Squibb, with nearly 20 years of experience in hematology/oncology nursing and a successful career in the biopharmaceutical industry.
Company
Lisa Gaston currently works at Bristol Myers Squibb. She holds the position of Associate Director, CAR T Training. Bristol Myers Squibb is known for its innovative contributions to the biopharmaceutical industry. Lisa's role focuses on training and educational initiatives related to CAR T-cell therapy, a cutting-edge approach in oncology treatment.
Title
Lisa Gaston holds the title of Associate Director, CAR T Training at Bristol Myers Squibb. This position involves specialized training programs and educational development in the CAR T-cell therapy domain, helping healthcare professionals to effectively handle this advanced therapeutic technology.
Education and Expertise
Lisa Gaston has a strong educational foundation in nursing and acute care. She earned her Bachelor of Science (BS) in Nursing Science from Purdue University, graduating in 1994. She further advanced her expertise by obtaining a Master of Science (M.Sc.) with a focus on Acute Care Nurse Practitioner from the University of Illinois at Chicago in 2002. Her extensive knowledge and nearly 20 years of experience in hematology/oncology have been pivotal in her career development.
Professional Background
Lisa Gaston's professional journey spans over two decades, beginning at the University of Illinois Medical Center where she served as an Acute Care Nurse Practitioner in the Bone Marrow and Stem Cell Transplant Program from 2002 to 2009. She then transitioned to Celgene, where she held various roles, including Clinical Nurse Consultant, Commercial Training Manager in Hematology, Manager of Clinical Nurse Consultants, and Associate Director for Central Region CNC Team. In 2021, she joined Bristol Myers Squibb as Associate Director of CAR T Training.
Industry Experience
Lisa Gaston has built a substantial career within the biopharmaceutical sector. Her transition from clinical practice to a clinical nurse consultant role in 2009 marked the beginning of her involvement in the biopharmaceutical industry. With nearly 20 years of experience in hematology and oncology, she has managed patients with hematological malignancies undergoing stem cell transplantation. Her expertise has been integral in developing training programs and leveraging clinical relationships in her various roles.